Leal Therapeutics, Inc. (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 30, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Company Description
- Leal Therapeutics, Inc. is a biotechnology company developing novel therapeutics for patients with disorders of the central nervous system (CNS).
- Market
- Central Nervous System Disorders
- Location
- Worcester, MA, USA
- Coinvestors
- Chugai Venture Fund, Alexandria Venture Investments, OrbiMed, Euclidean Capital, PhiFund